Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review-Reference-Cited by-同舟云学术

Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review

Published:2015-03-23 Issue:1 Volume:116 Page:30-36
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Kunath Frank¹²³,Grobe Henrik R.²⁴,Rücker Gerta⁵,Motschall Edith⁵,Antes Gerd²,Dahm Philipp⁶⁷,Wullich Bernd¹³,Meerpohl Joerg J.²

Affiliation:

1. Department of Urology; University Hospital Erlangen; Erlangen Germany

2. German Cochrane Centre; Medical Centre; University of Freiburg; Freiburg Germany

3. UroEvidence; Deutsche Gesellschaft für Urologie e.V.; Düsseldorf Berlin Germany

4. Department of General and Visceral Surgery; Medical Centre; University of Freiburg; Freiburg Germany

5. Centre for Medical Biometry and Medical Informatics; Medical Centre; University of Freiburg; Freiburg Germany

6. Urology Section 112D; Department of Veterans Affairs; University of Minnesota; Minneapolis MN USA

7. Department of Urology; University of Minnesota; Minneapolis MN USA

Funder

Deutsche Gesellschaft fÃ¼r Urologie

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13026/fullpdf

Reference29 articles.

1. Heidenreich A Bastian PJ Bellmunt J Bolla M Joniau S Mason MD Guidelines on Prostate Cancer 2013 www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf

2. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis;Seidenfeld;Ann Intern Med,2000

3. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American Society of Clinical Oncology practice guideline;Loblaw;J Clin Oncol,2007

4. Antiandrogen monotherapy: indications and results;Iversen;Urology,2002

5. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer;Kunath;Cochrane Database Syst Rev,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of the transactivation domain of androgen receptor as a therapy for prostate cancer;Steroids;2024-10

2. Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer;Cancers;2022-04-01

3. Neue Hormontherapien beim metastasierten Prostatakarzinom;Journal für Urologie und Urogynäkologie/Österreich;2021-08-13

4. Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients;Translational Andrology and Urology;2021-07

5. Neue Hormontherapien beim metastasierten Prostatakarzinom;Urologie in der Praxis;2021-06-04